# Kiora Pharmaceuticals Inc: Form DEF 14A, filed Mar 25, 2024

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: DEF 14A
- Filed: 2024-03-25
- Accepted by EDGAR: Mar 25, 2024, 16:32 ET
- Period: 2024-05-01
- Accession: 0001372514-24-000030
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000030/kiora-definitiveproxyxannu.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000030/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000137251424000030/kiora-definitiveproxyxannu.htm

Filed Mar 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001372514-24-000030. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
